RxDoctor Payments Data

Steven Seidel, MD

Plastic Surgery · Cullman, ALNPI 1265461008

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Merz North America, Inc. at 27.4% of the total. 2025 is the largest year on record at $782, 7.4 times the $106 reported in 2019. That places this record below the midpoint for plastic surgery clinicians in AL, where the typical reported total is $3,366.

$2,332in general payments, 2019–2025

Across 82 payments — averaging $28.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$638
  • AbbVie$402
  • Mentor Worldwide LLC$398
  • Revance Therapeutics, Inc.$248
  • TELA Bio, Inc.$133
  • Sientra, Inc.$120
  • plus $394 from 8 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sientra, Inc.$250

What the payments were for

  • Food & beverage$2,332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,332 in reported general payments places this provider in the 35th percentile of 35 plastic surgery providers in Alabama.

See all plastic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$119,708
Medicare patients
218
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine12$310
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$260
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$169
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$91

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Cullman

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →